A study for a 69 year old woman who takes Azithromycin, Januvia, Metrogel-Vaginal - from FDA reports

155 females aged 69 (┬▒5) who take the same drugs are studied. This is a personalized study for a 69 year old female patient who has Sinusitis, Diabetes, Vaginitis. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).

On Jul, 21, 2018

155 females aged 69 (┬▒5) who take Azithromycin, Januvia, Metrogel-Vaginal are studied.

Number of reports submitted per year:

Azithromycin, Januvia, Metrogel-Vaginal for a 69-year old woman.

Information of the patient in this study:

  • Age: 69
  • Gender: female
  • Conditions: Sinusitis, Diabetes, Vaginitis
  • Drugs taken:
    • Azithromycin (azithromycin)
    • Januvia (sitagliptin phosphate)
    • Metrogel-Vaginal (metronidazole)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  1. Skin ulcer
  2. Rashes (redness)
  3. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
  4. Joint stiffness
  5. Skin burning sensation
1 - 6 months:
  1. Hair loss
  2. Erythema multiforme (a type of hypersensitivity reaction)
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Hepatic function abnormal
  5. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
6 - 12 months:
  1. Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
1 - 2 years:
2 - 5 years:
5 - 10 years:
10+ years:
not specified:
  1. Tendonitis (a condition that causes pain and swelling of tendons)
  2. Osteopenia (a condition where bone mineral density is lower than normal)
  3. Cellulitis (infection under the skin)
  4. Dizziness
  5. Anaemia (lack of blood)

Top conditions involved for these people *:

  1. Multiple Myeloma (cancer of the plasma cells): 20 people, 12.90%
  2. Pain : 16 people, 10.32%
  3. Muscle Spasms (muscle contraction): 9 people, 5.81%
  4. Breast Cancer : 8 people, 5.16%
  5. Metastases To Bone (cancer spreads to bone): 8 people, 5.16%

Top co-used drugs for these people *:

  1. Levaquin (50 people, 32.26%)
  2. Zometa (47 people, 30.32%)
  3. Prednisone (46 people, 29.68%)
  4. Lyrica (38 people, 24.52%)
  5. Cymbalta (37 people, 23.87%)

* Some reports may have incomplete information.

FDA reports used in this study

You are not alone:

What are the drugs?

What are the conditions?

Related studies:

Related publications that referenced our studies

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.